Skip to main navigation Skip to search Skip to main content

Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures

  • Tommy Stödberg
  • , Amy McTague
  • , Arnaud J. Ruiz
  • , Hiromi Hirata
  • , Juan Zhen
  • , Philip Long
  • , Irene Farabella
  • , Esther Meyer
  • , Atsuo Kawahara
  • , Grace Vassallo
  • , Stavros M. Stivaros
  • , Magnus K. Bjursell
  • , Henrik Stranneheim
  • , Stephanie Tigerschiöld
  • , Bengt Persson
  • , Iftikhar Bangash
  • , Krishna Das
  • , Deborah Hughes
  • , Nicole Lesko
  • , Joakim Lundeberg
  • Rod C. Scott, Annapurna Poduri, Ingrid E. Scheffer, Holly Smith, Paul Gissen, Stephanie Schorge, Maarten E.A. Reith, Maya Topf, Dimitri M. Kullmann, Robert J. Harvey, Anna Wedell, Manju A. Kurian
  • Karolinska Institutet
  • University College London
  • Great Ormond Street Hospital for Children NHS Foundation Trust
  • Aoyama Gakuin University
  • Research Organization of Information and Systems, National Institute of Genetics Mishima
  • Japan Science and Technology Agency
  • New York University
  • University of London
  • University of Yamanashi
  • Manchester Academic Health Service (MAHSC)
  • University of Manchester
  • Uppsala University
  • Northern Care Alliance NHS Group
  • Young Epilepsy
  • KTH Royal Institute of Technology
  • Great Ormond Street Hospital for Children
  • Boston Children's Hospital
  • Harvard University
  • University of Melbourne
  • Florey Institute of Neuroscience and Mental Health

Research output: Contribution to journal › Article › peer-review

149 Scopus citations

Abstract

The potassium-chloride co-transporter KCC2, encoded by SLC12A5, plays a fundamental role in fast synaptic inhibition by maintaining a hyperpolarizing gradient for chloride ions. KCC2 dysfunction has been implicated in human epilepsy, but to date, no monogenic KCC2-related epilepsy disorders have been described. Here we show recessive loss-of-function SLC12A5 mutations in patients with a severe infantile-onset pharmacoresistant epilepsy syndrome, epilepsy of infancy with migrating focal seizures (EIMFS). Decreased KCC2 surface expression, reduced protein glycosylation and impaired chloride extrusion contribute to loss of KCC2 activity, thereby impairing normal synaptic inhibition and promoting neuronal excitability in this early-onset epileptic encephalopathy.

Original languageEnglish
Article number8038
JournalNature Communications
Volume6
DOIs
StatePublished - 3 Sep 2015
Externally publishedYes

Fingerprint

Dive into the research topics of 'Mutations in SLC12A5 in epilepsy of infancy with migrating focal seizures'. Together they form a unique fingerprint.

Cite this